Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs

Vaccine

Volumn 19, Issue 20-22, 2001, Pages 2783-2792

  Stanley, M A ^a   Moore, R A ^a   Nicholls, P K ^a   Santos, E B ^a   Thomsen, L ^b   Parry, N ^b   Walcott, S ^b   Gough, G ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

COPV; DNA; Vaccine

Indexed keywords

CANINE ORAL PAPILLOMAVIRUS; DNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; GENE; HEPATITIS VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUTH MUCOSA; NONHUMAN; PAPILLOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS INFECTION;

EID: 0035815517     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00533-8     Document Type: Article

References (29)

1. Human Papillomaviruses
2. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. In vitro and animal models for antiviral therapy in papillomavirus infections
5. Canine papillomavirus - A centenary review
6. Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine
7. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization
8. Canine papilloma: Progression of oral papilloma to carcinoma
9. Canine oral papillomatosis. I. Virus assay and observations on the various stages of the experimental infection
10. Naturally occurring, nonregressing canine oral papillomavirus infection: Host immunity, virus characterization, and experimental infection
11. Vaccination against papillomavirus in cattle
12. Cottontail rabbit papillomavirus L1 protein-based vaccines: Protection is achieved only with a full-length, nondenatured product
13. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
14. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: A canine model
15. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
16. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
17. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes
18. Exposing the immunology of naked DNA vaccines
19. Heterologous protection against influenza by injection of DNA encoding a viral protein
20. Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
21. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
22. Targeting the skin for genetic immunization
23. Protection against papillomavirus with a polynucleotide vaccine
24. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge
25. Immunization of pigs with a particle-mediated DNA-vaccine to infuenza A virus protects against challenge with homologous virus
26. Formalin-inactivated oral papilloma extracts and recombinant L1 vaccines protect completely against mucosal papillomavirus infection: A canine model
27. Spontaneously regressing oral papillomas induce systemic antibodies that neutralise canine oral papillomavirus
28. DNA vaccines